Efficacy and Safety of Benralizumab in Patients With Non-cystic Fibrosis Bronchiectasis

PHASE3TerminatedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 21, 2021

Primary Completion Date

April 16, 2024

Study Completion Date

April 16, 2024

Conditions
Non-cystic Fibrosis Bronchiectasis
Interventions
BIOLOGICAL

Benralizumab

Benralizumab active solution in a single accessorized prefilled syringe (APFS) will be administered subcutaneously (SC), 1 mL fill volume

BIOLOGICAL

Placebo to Benralizumab

Matching placebo solution in a single accessorized prefilled syringe (APFS) will be administered subcutaneously (SC), 1 mL fill volume

Trial Locations (48)

1100

Research Site, Quezon City

2650

Research Site, Hvidovre

2900

Research Site, Hellerup

3004

Research Site, Melbourne

4000

Research Site, San Miguel de Tucumán

4101

Research Site, South Brisbane

7100

Research Site, Vejle

9000

Research Site, Aalborg

20089

Research Site, Rozzano

20122

Research Site, Milan

28040

Research Site, Madrid

35233

Research Site, Birmingham

45239

Research Site, Essen

54907

Research Site, Jeonju

56100

Research Site, Pisa

60590

Research Site, Frankfurt

70000

Research Site, Hochiminh

79902

Research Site, El Paso

82131

Research Site, Gauting

91324

Research Site, Northridge

92663

Research Site, Newport Beach

100000

Research Site, Hanoi

100049

Research Site, New Delhi

200032

Research Site, Shanghai

410012

Research Site, Saratov

432009

Research Site, Ulyanovsk

440067

Research Site, Penza

450000

Research Site, Zhengzhou

500084

Research Site, Hyderabad

510120

Research Site, Guangzhou

641028

Research Site, Coimbatore

700000

Research Site, Ho Chi Minh City

B1602DQD

Research Site, Florida

B1646EBJ

Research Site, San Fernando

L1S 2J5

Research Site, Ajax

L7N 3V2

Research Site, Burlington

N8X-5A6

Research Site, Windsor

Unknown

Research Site, Guangzhou

D-80336

Research Site, München

00168

Research Site, Roma

85-079

Research Site, Bydgoszcz

27-400

Research Site, Ostrowiec Świętokrzyski

54-239

Research Site, Wroclaw

04763

Research Site, Seoul

05030

Research Site, Seoul

06591

Research Site, Seoul

08003

Research Site, Barcelona

SO9 4XY

Research Site, Southampton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY